|Articles|May 1, 2007
- Pharmaceutical Executive-05-01-2007
- Volume 0
- Issue 0
The Pharm Exec 50: Holding Pattern
The top 50 pharmaceutical companies, ranked by prescription pharmaceutical drug sales, plus rankings of top products, R&D spend, and more.
Advertisement
Articles in this issue
almost 19 years ago
Kid Tested, Government Approved?almost 19 years ago
Leadership: Getting on Boardalmost 19 years ago
Spend Trends 2007: Hang 10almost 19 years ago
The Secretalmost 19 years ago
Marketing to Professionals: No Sales Force, No Problemalmost 19 years ago
Opinion: Are Price Controls the New Black?almost 19 years ago
Toolkit: How To Be a Better Partneralmost 19 years ago
Washington Report: Pathways for Proteinsalmost 19 years ago
Global Report: Pure and Simplealmost 19 years ago
Thoughtleader: Thomas Nagle, Monitor GroupNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx Is Live and Complicated
2
Veradermics Raises $256 Million in Upsized Initial Public Offering
3
FDA Approves Vybrique to Treat Adult Men with Erectile Dysfunction
4
Pharmaceutical Executive Daily: FDA Approves First and Only Oral Film Treatment for Erectile Dysfunction
5